Filing Flows › Astrana Health (ASTH) › Q3 2026 › vs Q3 2025
Astrana Health (ASTH) Q3 2026 vs Q3 2025 (year over year)
Astrana Health's revenue rose $67.6M (+7%) from $956M in Q3 2025 to $1.0B in Q3 2026. The biggest changes: Health Care Capitation Revenue +$73.3M (+8%); Product and Service Other +$6.8M (+104%); Health Care Other −$6.5M (-21%). Operating margin 3.9% against 2.0% (+1.9 pts).
Astrana Health, Q3 2026: revenue $1.0B (+7% year over year), operating margin 3.9%, net earnings $13.0M, operating cash flow $16.3M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 3.9% | 2.0% | +1.9 pts |
| Net margin | 1.3% | 0.0% | +1.2 pts |
| Free cash flow margin | 1.2% | 0.8% | +0.4 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Health Care Capitation Revenue | $937M | $863M | $73.3M | +8% |
| Health Care Patient Service | $35.1M | $40.1M | −$5.0M | -12% |
| Health Care Other | $24.3M | $30.8M | −$6.5M | -21% |
| Management Service | $14.1M | $15.2M | −$1.1M | -7% |
| Product and Service Other | $13.4M | $6.6M | $6.8M | +104% |
| Revenue | $1.0B | $956M | $67.6M | +7% |
| Operating profit | $39.9M | $19.2M | $20.7M | +108% |
| Costs & expenses | $984M | $937M | $46.9M | +5% |
| Pre-tax earnings | $32.2M | $5.7M | $26.6M | +468% |
| Other expense, net | $7.7M | $13.5M | −$5.9M | -43% |
| Cost of revenue | $900M | $859M | $41.2M | +5% |
| General & admin | $68.0M | $62.4M | $5.7M | +9% |
| Other operating costs | $15.6M | $15.6M | $27K | +0.2% |
| Net earnings | $13.0M | $373K | $12.6M | 35× |
| Minority interests | $7.3M | $704K | $6.6M | +939% |
| Income tax | $12.0M | $4.6M | $7.4M | +160% |
| Operating cash sources | $44.1M | $23.7M | $20.5M | +86% |
| Depreciation & amortization | $15.6M | $15.6M | $27K | +0.2% |
| Share-based compensation | $15.6M | $7.7M | $7.9M | +102% |
| Working capital & other | $27.9M | $13.7M | $14.2M | +103% |
| Operating cash flow | $16.3M | $10.0M | $6.3M | +63% |
| Free cash flow (OCF − capex) | $12.4M | $7.4M | $5.0M | +68% |
| Capital expenditures | $3.8M | $2.6M | $1.3M | +50% |
Questions
How much did Astrana Health's revenue grow year over year in Q3 2026?
Astrana Health's revenue rose $67.6M (+7%) from $956M in Q3 2025 to $1.0B in Q3 2026.
What drove Astrana Health's revenue change in Q3 2026?
Health Care Capitation Revenue +$73.3M (+8%); Product and Service Other +$6.8M (+104%); Health Care Other −$6.5M (-21%).